CVI Holdings’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

CVI Holdings’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26,386	Closed	-$3.7K	–	312
2023 Q1	$3.7K	Sell	26,386 -3,614	-12%	-$514	﹤0.01%	340
2022 Q4	$2.55K	Hold	30,000	–	–	﹤0.01%	498
2022 Q3	$3K	Hold	30,000	–	–	﹤0.01%	767
2022 Q2	$8K	Hold	30,000	–	–	﹤0.01%	760
2022 Q1	$16K	Hold	30,000	–	–	﹤0.01%	809
2021 Q4	$35K	Hold	30,000	–	–	﹤0.01%	829
2021 Q3	$35K	Buy	+30,000	New	+$37.5K	﹤0.01%	800

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CVI Holdings's NKGNW Position: Q2 2023 in Review

CVI Holdings sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q2 2023, closing a stake of 26,386 shares — an estimated $3.7K sold.

CVI Holdings first reported a position in NKGNW in Q3 2021 and held it in 7 quarters. The position peaked at $35K in Q4 2021. 35 funds tracked by Wall St. Rank hold NKGNW as of Q2 2023.

CVI Holdings reported no remaining NKGen Biotech, Inc. Warrants position as of Q2 2023 after selling out during the quarter.
CVI Holdings sold 26,386 NKGen Biotech, Inc. Warrants shares in Q2 2023, an estimated $3.7K.
CVI Holdings first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 7 quarters.
CVI Holdings's NKGen Biotech, Inc. Warrants position peaked at $35K in Q4 2021.
35 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.